Learn

Infectious Diseases Research Review Issue 47 with commentary by Professor Tony Korman.

This review is a unique Australian publication providing topical, relevant and accessible information for health professionals with an interest in Infectious Diseases. In essence, the review is a summary of what we consider to be some of the most significant new studies in this area.

Details

In this edition we feature:

-  Immunogenicity and safety of a new yellow fever vaccine
-  Oral nirmatrelvir-ritonavir for COVID-19 in higher-risk outpatients
-  Group B Streptococcus vaccine in pregnant women and infants
-  Systematic SARS-CoV-2 screening in asymptomatic patients
-  Short-course antibiotics and single-dose fosfomycin for UTIs
-  Faecal microbiota transplant for multidrug-resistant organism decolonisation
-  Amoxicillin-clavulanate vs amoxicillin for acute sinusitis
-  Drugs as risk factors for Clostridioides difficile infections
-  Single-dose liposomal amphotericin for cryptococcal meningitis
-  Three months of weekly rifapentine and isoniazid for tuberculosis

To access this publication please click ‘Enrol Now’ and you’ll be directed to  the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au

This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide. 

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.